InsidersTradesSigma
SynAct Pharma AB Stock: price and management transactions · Finland · FIN-FSA
Follow the SynAct Pharma AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, SynAct Pharma AB has logged 8 public disclosures. Market capitalisation: €772.8m. The latest transaction was disclosed on 9 March 2026 (Purchase). Among the most active insiders: Thomas Jonassen. The full history is openly available.
8
Insider Decl.
0
Thresholds
€24,448
3 ops.
Buy Volume
€75,074
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate SynAct Pharma AB Strong Buy (bullish), based on 2 analysts. Average price target: SEK 34.65.
35Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 9 March 2026
Declarations8 total
7,900 shares@ €1.68490.0017% mcap100.0% of flowAktieFI:A003W854-1
Ideal exit: 30 Nov 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
2,700 shares@ €1.67050.0006% mcap100.0% of flowAktieFI:A003W815-1
Ideal exit: 28 Nov 2026 (T+270)
3,529 shares@ €1.87780.0008% mcap100.0% of flowAktieFI:A003V108-1
Ideal exit: 15 Sept 2026 (T+270)
15,275 shares@ SEK 49.6507100.0% of flowAktieFI:A001Q764-1
1,456,263 shares0AktieFI:A001P435-2
2,296,651 shares0AktieFI:A001P434-1
1,456,263 shares0AktieFI:A001P432-1
2,296,651 shares0AktieFI:A001P431-1
8 of 8 declarations